Tannenbaum Michael Benjamin 4
4 · Figure Technology Solutions, Inc. · Filed Apr 30, 2026
Research Summary
AI-generated summary of this filing
Figure (FIGR) CEO Michael Tannenbaum Sells Shares & Exercises Options
What Happened
- Michael Benjamin Tannenbaum, CEO of Figure Technology Solutions (FIGR), exercised 12,567 options at $4.82 each (cost ≈ $60,573) on April 28, 2026 and conducted multiple open‑market sales totaling 184,194 shares for approximately $6,064,355 on April 28–29, 2026. The sales were carried out in several blocks at weighted average prices between about $31.84 and $34.10 (see detailed ranges below). These were dispositions (sales), not purchases — commonly routine monetization rather than a bullish purchase signal.
Key Details
- Transaction dates: April 28–29, 2026. Form filed April 30, 2026 (timely — within the Form 4 reporting window).
- Exercise/acquisition: 12,567 shares acquired at $4.82 each (total ≈ $60,573).
- Dispositions (open market sales), grouped by reported line (weighted avg price / gross proceeds / price range per footnotes):
- 30,135 shares @ $32.31 — $973,547 (range $31.69–$32.68) (F2)
- 49,692 shares @ $33.26 — $1,652,731 (range $32.70–$33.68) (F3)
- 47,542 shares @ $34.10 — $1,621,101 (range $33.725–$34.36) (F4)
- 47,875 shares @ $31.84 — $1,524,345 (range $31.38–$32.285) (F5)
- 8,844 shares @ $32.69 — $289,077 (range $32.395–$33.39) (F6)
- 106 shares @ $33.53 — $3,554 (range $33.525–$33.5275) (F7)
- Total shares sold: 184,194; total gross proceeds ≈ $6,064,355.
- Additional derivative line: 12,567 shares listed as a conversion/exercise with $0 proceeds (reported as a derivative disposition) — represents the derivative conversion/settlement related to the option exercise (see F8).
- Shares owned after the transactions: not specified in the provided excerpt of the filing.
- Plan/authorization: Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted December 3, 2025 (F1).
Context
- The filing shows an option exercise plus substantial open‑market sales. Because the sales were executed under a pre‑arranged 10b5‑1 plan, they are typically considered routine sell‑side activity under an automated plan rather than a real‑time trading decision.
- F8 notes the option vesting schedule: one quarter vested April 22, 2025, with the remainder vesting in 36 monthly installments thereafter. The $0 derivative line reflects the mechanics of converting/exercising the option rather than cash proceeds.
Insider Transaction Report
Form 4
Tannenbaum Michael Benjamin
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2026-04-28$4.82/sh+12,567$60,573→ 3,377,835 total - Sale
Class A Common Stock
[F1][F2]2026-04-28$32.31/sh−30,135$973,547→ 3,347,700 total - Sale
Class A Common Stock
[F1][F3]2026-04-28$33.26/sh−49,692$1,652,731→ 3,298,008 total - Sale
Class A Common Stock
[F1][F4]2026-04-28$34.10/sh−47,542$1,621,101→ 3,250,466 total - Sale
Class A Common Stock
[F1][F5]2026-04-29$31.84/sh−47,875$1,524,345→ 3,202,591 total - Sale
Class A Common Stock
[F1][F6]2026-04-29$32.69/sh−8,844$289,077→ 3,193,747 total - Sale
Class A Common Stock
[F1][F7]2026-04-29$33.53/sh−106$3,554→ 3,193,641 total - Exercise/Conversion
Stock Option
[F8]2026-04-28−12,567→ 4,574,783 totalExercise: $4.82Exp: 2034-04-22→ Class A Common Stock (12,567 underlying)
Footnotes (8)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.69 to $32.68. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.70 to $33.68. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.725 to $34.36. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.38 to $32.285. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.395 to $33.39. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.525 to $33.5275. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The option vested with respect to one quarter of the underlying shares on April 22, 2025, and vests with respect to the remaining shares in 36 monthly installments thereafter.
Signature
/s/ Ronald Chillemi, Attorney-in-Fact|2026-04-30